ArticleScientific reports2026
ZIF-8 functionalized PCL/BG composite scaffolds with improved bioactivity and osteogenic differentiation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Apt19s-functionalized 3D-printed PCL/58S bioactive glass scaffoldsRSC advances · 2026Article
- Construction ofRegenerative biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone tissue engineering requires scaffolds with balanced mechanical strength, bioactivity, and biological performance. In this study, three-dimensional (3D) printed polycaprolactone (PCL) scaffolds incorporating 40, 45, and 50 wt% sol–gel-derived 58 S bioactive glass (BG) nanoparticles were fabricated, followed by surface functionalization with a ZIF-8 metal–organic framework to develop a dual bulk–surface modified system. Among the investigated compositions, the scaffold containing 45 wt% BG exhibited the highest compressive strength (~ 35 MPa) and was selected as the optimized formulation for subsequent biological evaluation. Cross-sectional SEM and EDS analyses confirmed the homogeneous dispersion of Ca, Si, and P elements throughout the polymer matrix. The optimized scaffold demonstrated controlled degradation behavior and pronounced apatite-forming ability in simulated body fluid. Quantitative Zn²⁺ ion release analysis over 28 days revealed a sustained and controlled release profile (0.05–0.69 ppm) without burst release, indicating the structural stability of the ZIF-8 coating and maintaining ion concentrations within a non-toxic range. In vitro studies using MG-63 osteoblast-like cells showed significantly enhanced cell viability, adhesion, and proliferation in the ZIF-8-modified scaffold compared to the uncoated group (p < 0.05). Furthermore, gene expression analysis demonstrated significant upregulation of osteogenic markers (ALP, Col1A1, Runx2, and OCN) in the surface-functionalized scaffold, confirming its osteoinductive potential. Overall, the combined high BG loading and ZIF-8 surface modification strategy resulted in a mechanically competent, bioactive, and biologically enhanced scaffold, highlighting its promise as a multifunctional platform for bone tissue engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.